Categories Health Care, LATEST

Trxade launches integrated COVID-19 risk assessment tool for corporate clients

The mobile dashboard will be part of Trxade’s telehealth business unit Bonum Health

Integrated drug procurement firm Trxade Group (NASDAQ: MEDS) on Tuesday launched a one-of-its-kind platform that brings together various services such as COVID-19 risk assessment, PPE shopping, and telehealth for its corporate customers.  

The mobile dashboard, christened Bonum+, is part of Trxade’s Bonum Health unit and allows companies to streamline PPE purchases, besides keeping a track on employee risk profiles. The platform also leverages artificial intelligence capabilities to connect employees with certified physicians.

Bonum Health President Ashton Maaraba said,  “This platform resolves a fundamental trust problem impacting employer’s safety and security policies, allowing companies to more effectively combat COVID-19 concerns in the workplace.”

[irp posts=”67637″]

He added that Bonum Health is looking forward to expanding the tool’s capabilities to include other key features including prescription concierge services.   

When the Tampa, Florida-based firm reported second-quarter results late last month, it was evident that the high demand for personal protective equipment (PPE) including N-95 masks and sanitizers had benefited it’s topline. Revenue rose 244%, well above street expectations, sending the stock up 35% immediately following the announcement.

Trxade Group Q2 2020 earnings results.

However, lower margins on PPE had hurt the firm’s overall margins during the quarter.

MEDS shares were trading 0.3% higher following the launch announcement on Tuesday. The stock has declined 8% since the beginning of this year.


Most Popular

V Earnings: Key quarterly highlights from Visa’s Q1 2023 financial results

Visa Inc. (NYSE: V) reported first quarter 2023 earnings results today. Net revenues grew 12% year-over-year to $7.9 billion. GAAP net income rose 6% to $4.2 billion while EPS grew

Earnings: Highlights of Intel’s (INTC) Q4 2022 financial results

Intel Corporation (NASDAQ: INTC) Thursday reported a decline in adjusted earnings and revenues for the fourth quarter. The semiconductor giant also provided guidance for the first quarter of 2023. Fourth-quarter

McCormick (MKC) expects to drive sales growth in 2023 through pricing actions and cost savings

Shares of McCormick & Company Inc. (NYSE: MKC) were down over 5% on Thursday after the company missed expectations on its fourth quarter 2022 results and provided a lower-than-expected earnings

Add Comment
Viewing Highlight